HIKAL

What Hikal promised, and what happened

Every commitment management made on a call, tracked from the quarter it was made — reaffirmed, revised, diluted or quietly dropped.

Guidance record · Q1 FY27

what the last two calls moved 26 tracked 4 delivered 5 missed 17 open
  • Crop Protection Revenue Growth delivered said Q4 FY25 Promised: Muted/Flattish in FY26 Q1 FY27: Promise pertains to FY26, which is complete. Verdict stands.
  • Pharma Business Revenue Growth missed said Q4 FY25 Promised: 12-15% growth in FY26 Q1 FY27: Promise pertains to FY26, which is complete. Verdict stands.
  • Completion of CAPA for US FDA OAI delayed said Q1 FY26 Promised: Remaining balance to be closed out before end of this quarter (Sept 2025) Q1 FY27: Timeline pushed further. Management now expects re-inspection 'towards the end of this financial year' (FY27), a delay from the previous 'end of 2026' guidance.

The rest of the ledger

Above is what the last two calls moved. Pro opens all 26 tracked commitments for Hikal — every quarter's revision, the source quote behind each one, and the topics management has stopped answering.

See what Pro opens